Countable Labs raises $26m for PCR technology advancement
Countable Labs has raised $26m to advance the development and commercialisation activities for its single-molecule polymerase chain reaction (PCR) technology.…
29 May 2026
Coredio’s AI heart failure software secures breakthrough designation
Coredio’s haemodynamic heart failure (HF) assessment software has obtained breakthrough device designation from the US Food and Drug Administration (FDA). The California-based digital health company’s cardiac performance simulation engine (CPSE)…
29 May 2026
Illumina and SPT Labtech launch fireflyGO for automated oncology research
Illumina and SPT Labtech have launched the fireflyGO automation platform, designed to accelerate and simplify targeted oncology research. The new benchtop system provides laboratories with automated liquid handling and library…
29 May 2026
Procept secures FDA IDE for Aquablation and completes WATER IV study enrolment
Procept BioRobotics has received a second FDA investigational device exemption (IDE) to allow another randomised study of its Aquablation therapy. The regulatory clearance permits the start of a study comparing…
28 May 2026
Abbott obtains CE mark for duo of glucose-ketone monitors
Medtech giant Abbott has secured a CE mark for two of its glucose-ketone sensing systems for diabetic patients, making the devices the first of their kind to reach this milestone.…
27 May 2026
AiM Medical to integrate robotic neurosurgery system with Siemens’ MRI systems
AiM Medical Robotics (AiM) has signed an agreement with Siemens Healthineers to develop an interface that will allow AiM’s robotic neurosurgery platform to integrate with Siemens Healthineers’ magnetic resonance imaging…
27 May 2026
ABILITY Neurotech receives MREC approval for ALS BCI clinical trial
ABILITY Neurotech has secured approval from the Medical Research Ethics Committee (MREC) NedMec in the Netherlands to initiate a chronic clinical trial of its fully implantable wireless brain-computer interface (BCI)…